Louis M. Aledort, MD, Receives Lifetime Achievement Award From Albert Einstein College of Medicine
Dr. Aledort was recognized for his distinguished career in the field of blood disorders, his academic research and his community and service efforts.
Louis M. Aledort, MD, The Mary Weinfeld Professor of Clinical Research in Hemophilia at Mount Sinai School of Medicine , has received of the prestigious Albert Einstein College of Medicine Lifetime Achievement Award in recognition of his distinguished career in the field of blood disorders and his major contributions to the health and welfare of underserved communities. He received the award Wednesday, June 1, at the Albert Einstein College of Medicine Commencement.
"As a physician and a public health leader, Dr. Aledort has demonstrated the qualities that we hold dear: caring and humanity, a sense of concern for the individual and, in particular, a deep and rewarding commitment to serve society,"said Stephen E. Goldstone, MD, President of Albert Einstein College of Medicine Alumni Association and Assistant Clinical Professor of Surgery at Mount Sinai School of Medicine. "It’s a privilege to publicly acknowledge the deep respect and admiration he has earned from this community."
A pioneer in the study and treatment of coagulation disorders, Dr. Aledort continues to be the one of the world’s leading authorities on hemophilia. He has long been at the forefront of developing comprehensive care for hemophilia, including creating The Mount Sinai Regional Comprehensive Hemophilia Treatment Center, which has been designated as a World Health Organization Global Cooperating Training Center in Coagulation Diseases.
"I’m extremely proud to be recognized by my peers with this prestigious award. It’s Einstein’s highest honor,"said Dr. Aledort. "I have been involved in this field for over 50 years, through my academic research and community and service efforts. I look forward to continuing my work for years to come."
A strong voice for patient care, Dr. Aledort led the way in obtaining congressional appropriations for regional treatment centers and helped to make third-party carriers in New York City aware of the need to provide treatment that maintains patients' function. Dr. Aledort has worked with national and international groups to make clotting materials available to patients and helped to develop an international educational program for patients and their physicians. His international work has included collaborating with organizations and colleagues in Turkey, Argentina, China, India and Brazil, where a hemophilia center in São Paulo has been named in his honor.
Dr. Aledort has been a leader in the design and implementation of several groundbreaking collaborative study groups, including the U.S. Hemophilia Study Group, the Transfusion Safety Study, and the Orthopedic Outcome Study. He has authored more than 400 peer-reviewed articles in prominent journals, including Haemophilia, Journal of Thrombosis and Haemostasis, and the American Journal of Hematology.
In addition to his own research and the mentorship of his peers, Dr. Aledort is involved in several professional organizations, including the American Society of Hematology, the International Society of Hematology, and the American College of Physicians, for whom he is a Master. He is the editor of numerous medical journals, has held nearly 50 major positions at governmental, non-profit, and educational organizations, and served on several academic advisory committees.
Dr. Aledort earned his medical degree at the Albert Einstein College of Medicine of Yeshiva University as a member of its first graduating class, in 1959. He continued his studies as a resident at the University of Virginia and at Strong Memorial Hospital in Rochester, NY, where he also had a Hematology Fellowship. From Rochester, Dr. Aledort joined Mount Sinai, where he has remained for 45 years. About The Mount Sinai Medical Center
The Mount Sinai Medical Center encompasses both The Mount Sinai Hospital and Mount Sinai School of Medicine. Established in 1968, Mount Sinai School of Medicine is one of few medical schools embedded in a hospital in the United States. It has more than 3,400 faculty in 32 departments and 15 institutes, and ranks among the top 20 medical schools both in National Institute of Health funding and by U.S. News & World Report. The school received the 2009 Spencer Foreman Award for Outstanding Community Service from the Association of American Medical Colleges.
The Mount Sinai Hospital, founded in 1852, is a 1,171-bed tertiary- and quaternary-care teaching facility and one of the nation’s oldest, largest and most-respected voluntary hospitals. In 2009, U.S. News & World Report ranked The Mount Sinai Hospital among the nation’s top 20 hospitals based on reputation, patient safety, and other patient-care factors. Nearly 60,000 people were treated at Mount Sinai as inpatients last year, and approximately 530,000 outpatient visits took place.
For more information, visit www.mountsinai.org.